ZA200004387B - Anti-tumour agents. - Google Patents
Anti-tumour agents.Info
- Publication number
- ZA200004387B ZA200004387B ZA200004387A ZA200004387A ZA200004387B ZA 200004387 B ZA200004387 B ZA 200004387B ZA 200004387 A ZA200004387 A ZA 200004387A ZA 200004387 A ZA200004387 A ZA 200004387A ZA 200004387 B ZA200004387 B ZA 200004387B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- hydrogen
- tumour agents
- akanesulphonyloxy
- alkanesulphonyloxy
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- -1 benzenesulphonyloxy Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805866.2A GB9805866D0 (en) | 1998-03-20 | 1998-03-20 | Anti-tumour agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200004387B true ZA200004387B (en) | 2001-10-31 |
Family
ID=10828858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200004387A ZA200004387B (en) | 1998-03-20 | 2000-08-24 | Anti-tumour agents. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6346633B1 (xx) |
| EP (1) | EP1064253B1 (xx) |
| JP (1) | JP2002507590A (xx) |
| KR (1) | KR20010042055A (xx) |
| CN (1) | CN1293654A (xx) |
| AT (1) | ATE231835T1 (xx) |
| AU (1) | AU756651B2 (xx) |
| BR (1) | BR9908932A (xx) |
| CA (1) | CA2324361A1 (xx) |
| DE (1) | DE69905142T2 (xx) |
| DK (1) | DK1064253T3 (xx) |
| ES (1) | ES2190199T3 (xx) |
| GB (1) | GB9805866D0 (xx) |
| IL (1) | IL138589A (xx) |
| NO (1) | NO20004662L (xx) |
| NZ (1) | NZ505856A (xx) |
| WO (1) | WO1999048857A1 (xx) |
| ZA (1) | ZA200004387B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9805868D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
| US20060099712A1 (en) * | 2004-11-08 | 2006-05-11 | Eastman Kodak Company | Correlation of anti-cancer activity of dyes with redox potentials |
| CA3029228A1 (en) * | 2016-06-27 | 2018-01-04 | Systems Oncology, Llc | Combination chemotherapies |
| JP2022526450A (ja) * | 2019-04-12 | 2022-05-24 | トニックス ファーマシューティカルズ ホールディング コーポレーション | Ｃｄ４０－ｃｄ１５４結合の阻害剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0002677B1 (en) | 1977-12-02 | 1982-10-13 | Takeda Chemical Industries, Ltd. | Glucosamine-peptide derivatives and their pharmaceutical compositions |
| JPS58177934A (ja) * | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
| NZ240785A (en) * | 1991-11-28 | 1995-08-28 | Cancer Res Campaign Tech | Substituted nitro aniline derivatives and medicaments |
| GB9805868D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
-
1998
- 1998-03-20 GB GBGB9805866.2A patent/GB9805866D0/en not_active Ceased
-
1999
- 1999-03-16 BR BR9908932-7A patent/BR9908932A/pt not_active IP Right Cessation
- 1999-03-16 US US09/646,459 patent/US6346633B1/en not_active Expired - Fee Related
- 1999-03-16 EP EP99909099A patent/EP1064253B1/en not_active Expired - Lifetime
- 1999-03-16 NZ NZ505856A patent/NZ505856A/xx unknown
- 1999-03-16 IL IL13858999A patent/IL138589A/en not_active IP Right Cessation
- 1999-03-16 KR KR1020007010399A patent/KR20010042055A/ko not_active Ceased
- 1999-03-16 DE DE69905142T patent/DE69905142T2/de not_active Expired - Fee Related
- 1999-03-16 AU AU28468/99A patent/AU756651B2/en not_active Ceased
- 1999-03-16 ES ES99909099T patent/ES2190199T3/es not_active Expired - Lifetime
- 1999-03-16 CN CN99804243A patent/CN1293654A/zh active Pending
- 1999-03-16 AT AT99909099T patent/ATE231835T1/de not_active IP Right Cessation
- 1999-03-16 WO PCT/GB1999/000787 patent/WO1999048857A1/en not_active Ceased
- 1999-03-16 CA CA002324361A patent/CA2324361A1/en not_active Abandoned
- 1999-03-16 DK DK99909099T patent/DK1064253T3/da active
- 1999-03-16 JP JP2000537842A patent/JP2002507590A/ja active Pending
-
2000
- 2000-08-24 ZA ZA200004387A patent/ZA200004387B/xx unknown
- 2000-09-19 NO NO20004662A patent/NO20004662L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1064253B1 (en) | 2003-01-29 |
| CN1293654A (zh) | 2001-05-02 |
| GB9805866D0 (en) | 1998-05-13 |
| ES2190199T3 (es) | 2003-07-16 |
| DE69905142D1 (de) | 2003-03-06 |
| NZ505856A (en) | 2002-09-27 |
| NO20004662L (no) | 2000-11-17 |
| ATE231835T1 (de) | 2003-02-15 |
| EP1064253A1 (en) | 2001-01-03 |
| CA2324361A1 (en) | 1999-09-30 |
| US6346633B1 (en) | 2002-02-12 |
| WO1999048857A1 (en) | 1999-09-30 |
| IL138589A0 (en) | 2001-10-31 |
| DE69905142T2 (de) | 2003-10-16 |
| KR20010042055A (ko) | 2001-05-25 |
| NO20004662D0 (no) | 2000-09-19 |
| AU2846899A (en) | 1999-10-18 |
| AU756651B2 (en) | 2003-01-16 |
| IL138589A (en) | 2004-08-31 |
| JP2002507590A (ja) | 2002-03-12 |
| BR9908932A (pt) | 2005-10-25 |
| DK1064253T3 (da) | 2003-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112609D1 (en) | Pyrazolopyridine | |
| MXPA02012425A (es) | Compuestos nuevos. | |
| MX9408969A (es) | Composisciones farmaceuticas que comprenden microparticulas biodegradables y biocompatibles para el tratamiento de transtornos psicoticos, su uso y procedimiento para prepararlas. | |
| PL337329A1 (en) | Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group | |
| AU6831498A (en) | Fluorescent whitening agents | |
| TW282456B (xx) | ||
| GEP20084488B (en) | Use of therapeutic agents for treating pain | |
| AU7700096A (en) | Novel 2,3,5-trimethyl-4-hydroxyanilide derivatives, their preparation and their application in therapeutics | |
| MXPA04000814A (es) | Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo. | |
| TR200103683T2 (tr) | Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı | |
| NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
| GB9805868D0 (en) | Anti-tumour agents | |
| AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
| BG104617A (en) | Novel naphthyl-substituted and anilide-substituted sulfonamides | |
| GB9805866D0 (en) | Anti-tumour agents | |
| GB9824207D0 (en) | Neurological disorders | |
| MY135774A (en) | Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them. | |
| MXPA04001773A (es) | Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos. | |
| IL150605A0 (en) | Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same | |
| PL335012A1 (en) | Novel derivatives of indan-1-ole, method of obtaining and composition containing them | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| TNSN06142A1 (en) | Cycloalkyl derivatives of 3-hydroxy-4-pyridinones | |
| YU23498A (xx) | Herbicidni 3,5-difluoropiridini | |
| TW200505338A (en) | Pyrazole compound | |
| MX9705378A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad. |